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ABSTRACT
Inorganic CsPbBr3 perovskite devices have been manufactured and tested as dosimeters under both conventional and Intensity Modulated
Radiotherapy (IMRT) X-ray beams. Samples showed a very good linear dependence of the collected charge/current on dose/dose rates in
the range of 0.1–5.0 Gy/0.1–4.0 Gy/min of interest for clinical applications. A device sensitivity of about 70 nC/Gy mm3 compares favorably
with other solid-state dosimeters. The first verification of an IMRT dose profile of a prostate cancer treatment, performed by moving the
perovskite device on a 10 cm-long profile with a 0.5 mm pitch, showed agreement within 5% with the dose distribution required by the
treatment planning system.
© 2019 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.5083810
I. INTRODUCTION
Modern radiotherapy techniques, such as X-photon Intensity
Modulated RadioTherapy (IMRT) and Volumetric Modulated Arc
Therapy (VMAT), deliver highly conformed doses to irregularly
shaped tumor volumes to spare surrounding healthy tissues.1,2 The
consistency between dose maps calculated by a dedicated Treatment
Planning System (TPS) and those actually delivered to the patient
have to be carefully checked experimentally either before or during
the patient treatment. Modern dosimetric systems need precise mea-
surements of the dose map distributions, characterized by high spa-
tial resolutions. For this purpose, the active volume of the dosimeter
must be minimized; therefore, a material with high sensitivity per
unit volume is required.
Solid-state dosimeters behave as ionization chambers during
X-ray irradiation; electron-hole pairs are generated in the semicon-
ductor bulk and then collected by the electric field applied across
electrodes.3 The charge Q collected at electrodes, in general, has a
linear dependence on the absorbed dose, D, and sensitivity per unit
volume is given by S = QD Volume = qGR , with G being the electron-
hole pair generation rate, R being the absorbed dose rate, and q
being the electronic charge. The generation rate is related to the dose
rate R by G = RρEi , with ρ being the density and Ei being the mean
energy to create an electron-hole pair.4 Thus, the sensitivity S per
unit volume is ultimately ruled out by the ratio between density and
mean energy for pair production: S = qρEi . State-of-art dosimeters for
clinical radiotherapy are ionization chambers (ICs) filled with air,
silicon diodes, and, more recently, also diamond films. As an exam-
ple, Table I shows a list of relevant parameters for three radiotherapy
dosimeters based on ICs,5 Si diodes,4,6 and single-crystal Chemical
Vapor Deposited (CVD) diamond, respectively.7 The first two are
modular arrays developed specifically for IMRT applications, while
the third is a pin-point device, a bidimensional device based on this
material being still under development.8
In clinical radiotherapy, X-ray beams are characterized by high
dose rates and high energy in the 0.05–18 Gy/min and MeV ranges,
respectively, much higher than those used for X-ray inspection and
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TABLE I. Relevant properties of commercial dosimetric devices used in clinical radiotherapy applications.
IC (air) Silicon Diamond
ρ (g/cm3) 1.29 × 10−3 2.33 3.52
Ei (eV) 34.00 3.60 16.20
S (nC/Gy mm3) 0.038 647.22 217.28
Area (mm2) 25.00 0.64 3.80
Thickness (mm) 5.00 0.03 0.001
Volume (mm3) 125 0.019 0.0038
Array OCTAVIUS PTW MAPCHECK . . .
SunNuclear
Detector 729 PTW SunPoint® MicroDiamond
diode detector type 60019 PTW
Reference 5 6 7
imaging, where dose rates are of the order of few micrograys per
second and energy is hundreds of keV. With dose-rates and energies
typical of clinical radiotherapy, a volume of about 1 mm3 or less is
sufficient to get currents of the order of 1 nA from a semiconduc-
tor device, this brings to adopting active layers of small thickness
(not in the case of ionization chambers, where the low density of
air needs for higher volume and depth). Moreover, a thick slab of a
semiconductor material would suffer from a reduction in sensitiv-
ity with the accumulated dose due to the diffusion length decrease
caused by radiation-induced defects.9 In fact, commercial silicon
and diamond devices are characterized by a thickness of the order of
1–30 µm (see Table I).
In CsPbBr3, the mean energy to create an electron-hole pair has
been estimated as ECsPbBr3 ∼ 5.3 eV10 by extrapolating results from
a class of compound materials used in X-ray detection.11 Consid-
ering ρCsPbBr3 = 4.55 g/cm
3, one obtains a theoretical value sCsPbBr3∼ 860 nCGy mm3 , much higher than that of silicon and far above that of
diamond. This material is even more favorable than MAPbBr3: in
fact, given ρMAPbBr3 = 3.83 g/cm312 and EMAPbBr3 = 6.03 eV,
13 one
obtains a theoretical value sMAPbBr3 ∼ 635 nCGy mm3 , lower than that
of CsPbBr3. CsPbBr3 has already been proposed as an X-ray pho-
todetector and imaging device in medical applications,14–17 but up
to now, no work has been carried out to demonstrate the feasibility
of using this material to produce and test photoconductive dosime-
ters for clinical radiotherapy. Moreover, there is a second impor-
tant reason that makes it extremely interesting to develop CsPbBr3
dosimeters for clinical radiotherapy. Modern systems involve three-
dimensional geometries, often based on nonplanar arrangements,
e.g., cylindrical water-equivalent phantoms equipped with three-
dimensional arrays of detectors placed in a helicoidal pattern.18
Solid-state semiconductor devices, such as silicon diodes and dia-
mond Schottky barriers, are manufactured from semiconductor
wafers, rigid and with flat geometry, not suitable for nonplanar
geometry arrangements. CsPbBr3 inorganic perovskites can be in
principle easily deposited on flexible large area supports to create
a multipoint device adjustable on any kind of shape. This adding
value of CsPbBr3 makes this material a very promising candidate for
modern clinical dosimetry applications.
In this work, we present a first proof-of-principle experi-
mental study on the feasibility of CsPbBr3 dosimeters for clinical
radiotherapy, with particular focus to IMRT modality. We manu-
factured a set of point devices by depositing thin films on custom
printed circuit boards (PCB) equipped with electrodes and tested
them under clinical X-ray beams used in advanced radiotherapy
accelerators, in view to develop advanced dosimetric systems for
modern clinical radiotherapy.
II. EXPERIMENTAL PROCEDURE
CsPbBr3 films have been deposited by drop-cast directly on alu-
mina Printed Circuit Board (PCB) specially designed for electrical
tests of thin semiconductor films. The perovskite film is obtained
starting from CsBr and PbBr2 salts (Acros Organics, >99%) mole
ratio 1:1 in a dimethyl sulfoxide (DMSO, from Sigma-Aldrich) sat-
urated solution. Thermal annealing at 150 ○C eliminates traces of
the solvent and returns a layer of interconnected CsPbBr3 micro-
crystals of the order of a few micrometer. The alumina PCBs have
two parallel gold contacts, 7 mm long and spaced 0.8 mm, 20 µm
thickness. Figure 1(a) shows a picture of one of the devices tested
in this study in X-ray diffraction inspection, shown in Fig. 1(b),
together with XPS analysis, demonstrated the excellent quality of
the film in the absence of residual precursors and contaminants.
Figure 1(c) shows an SEM photograph evidencing the microcrys-
talline nature of the film. Low temperature (10 K) photolumines-
cence analysis [Fig. 1(d)] carried out on a similar drop-casted sam-
ple deposited on a glass substrate evidenced high-quality emission
properties, similar to the literature data.19 Soon after deposition, we
covered the perovskite film with a polymethylmethacrylate (PMMA)
layer to prevent degradation due to air and moisture contact and
to favor electronic equilibrium during the exposure to therapeutic
X-ray beams.
A recent study on the photoconductive properties of similar
samples showed a resistivity in the dark about 109 Ω cm and a posi-
tive value of the Hall coefficient RH ∼ 1010 cm3/C, indicating p-type
conductivity with a Hall mobility µH = RH/(rHρ) ∼ 10 cm2/(Vs).20
We tested the dosimetric properties of our devices with clinical X-
ray beams delivered by linear accelerators (LINAC) routinely used
for patient treatments at the Radiotherapy Unit of the University
Hospital in Florence. A Precise Elekta linac delivering 6 MV and
25 MV X-ray beams (meaning that X-ray highest energy is 6 MeV
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FIG. 1. (a) Photograph of the CsPbBr3 film deposited on
the alumina substrate carrying two parallel gold contacts,
(b) XRD spectrum of the film, (c) SEM image showing the
microcrystalline nature of the deposit, and (d) photolumines-
cence spectrum of a similar drop-casted sample deposited
on a glass substrate.
and 25 MeV, respectively), in the nominal dose rate range of 0.5–4
Gy/min, was used. The linac dose rate was checked during the tests
using the ionization chambers placed within the linac; it is stable
within 0.01 Gy/min. Each perovskite-based device has been placed
at the isocenter, namely, at Source Axis Distance (SAD) = 100 cm,
corresponding to Source Skin Distance SSD = 95 cm, beyond a 5 cm-
thick polymethylmethacrylate layer to ensure electronic equilibrium
during irradiation. A first test has been carried out with a uniform
squared field of irradiation (40 × 40 cm2) and linac gantry at an
angle of 0○ to determine the sensitivity of our devices to doses and
dose/rates typically used in clinical radiotherapy. Current flowing
across the two electrodes, biased with a constant voltage of 5 V,
was read out by a Keithley 6517 electrometer (also used as a voltage
source) driven by a Matlab software toolkit. The current response
has been read out during irradiation; the device has been tested
under doses (0.1–5.0 Gy) and dose rates (50–400 cGy/min) of inter-
est in clinical radiotherapy. A moderate drift of the current stabilized
itself after the first minutes of voltage application. The device is
also sensitive to local temperature changes, which can occur dur-
ing irradiation and give rise to fluctuations in the baseline due to
the dark current, which is anyway subtracted from the photocurrent
signal.
A second test has been carried out to investigate the per-
formance of our perovskite-based dosimeter in a high conformal
radiotherapy technique such as IMRT (Intensity Modulated Radio-
Therapy). An Elekta Synergy linac equipped with a Multi-Leaf Col-
limator (MLC) composed of 80 4 mm-thick leaves has been used
to deliver a clinical 10 MV photon beam out of five planned for an
IMRT prostate treatment. The IMRT treatment was delivered in the
step-and-shoot modality which means that dose is released during a
discrete set of irradiation steps, each characterized by a selected con-
figuration of the MLC, in view to have a suitable aperture shape at
the linac head (segment), irradiating only when leaves are station-
ary at each position. The dose bidimensional map is obtained by
summing 12 successive segments, with gantry placed at 0○, carried
out with a nominal dose rate of 400 cGy/min, each with a different
spatial distribution. Each segment has a duration of a few seconds;
the entire radiation treatment lasts about 1 min. Figure 2 shows the
TPS IMRT dose map of the beam used in this work. We tested our
FIG. 2. TPS map of doses, typical of a prostate cancer treatment used in this
study: GT = gantry target direction and LL = lateral–lateral direction (isocenter at
the intersection of the white lines). The solid red line indicates the profile studied
in this work.
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device acquiring data along a lateral-lateral profile passing through
the isocenter (shown in Fig. 2) by changing its position from bottom
to top with 5 mm-pitch, for a total elongation of 10 cm. We mea-
sured the current during each segment, and we calculated the total
collected charge by integrating the overall signal during time, after
subtracting the baseline due to dark current. Baseline fluctuations
during measurement are lower than 1% of the signal.
III. EXPERIMENTAL RESULTS
Figure 3(a) shows the photocurrent (after the dark current sub-
traction) measured by our device when biased with 5 V and irra-
diated by a 25 MV X-ray beam with pulses of increased duration.
Each pulse, delivered with the same dose rate (200 cGy/min), refers
to a different dose value in the range of 0.1–5 Gy of interest in
FIG. 3. (a) Current signal as a function of time measured during repeated pulses
of different duration with the CsPbBr3 film (5 V bias) under an X-ray beam with the
25 MeV highest energy. (b) Charge obtained by integrating current signals shown
in (a), plotted as a function of the dose with a linear best fit. (c) Comparison of
current signals measured in the low dose range of 10–50 cGy, linear behavior of
the charge vs dose in the same range.
clinical radiotherapy. Figure 3(b) shows the collected charge
obtained by integrating such current signals, plotted as a function
of the dose. The best fit of data evidences an excellent linear trend,
indicating a constant sensitivity in the overall investigated range,
even in the low dose range, with very short pulses. Figure 3(c) shows
a comparison of the current signals measured up to 50 cGy: signal
transients are rather slow but well reproducible at any investigated
duration. A very good linear trend in the whole charge vs dose inves-
tigated range is obtained (see the inset), characterized by the same
slope and almost the equal intercept.
We calculated the sensitivity of our device to dose as the slope
of the linear plot of charge vs dose shown in Fig. 3(b), S = QD= 7.82 nCGy , considering the geometry of this device, a sensitivity per
unit volume: s = 69.8 nCGy mm3 is obtained. The intercept of the curve,
q = 48.5pC, can be considered as the resolution in charge of our
device, corresponding to about 6.2 mGy. The dose-rate dependence
of the current response of our perovskite device has been investi-
gated with another sample under a 6 MV X beam in the range of
0.5–4 Gy/min of interest in clinical radiotherapy. Current signals are
shown in Fig. 4(a); the average current measured at signal saturation
at each dose rate is plotted against the dose rate in Fig. 4(b).
The sensitivity of our device, in this case, is SDr = ∆IDr = 5.9 nCGy .
Considering the geometry of this sample, the sensitivity per unit
FIG. 4. (a) Current signal measured with a CsPbBr3 dosimeter (Vbias = 5 V) when
irradiated under 6 MV X-rays with four different dose rates and same total dose (2
Gy) and (b) current signal measured at saturation plotted as a function of the dose
rate and best-fit showing a linear behavior.
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volume is s = 70.5 nCGy mm3 , in good agreement with results obtained
when charge vs dose and a 6 MV X beam has been used.
The good linear dependence against dose and dose rate, as well
as stable and reproducible responses measured under conventional
uniform radiation fields, is a promising feature for achieving good
results also in high conformal radiation modality such as intensity
FIG. 5. (a) Current and (b) charge signals measured with the perovskite dosime-
ter under the IMRT beam (bias 5 V) of the TPS map shown in Fig. 2. (c) Dose
profile, relative to isocenter, measured with the perovskite-based dosimeter and
with an array of commercial Si diodes (MAPCHECK by Sun Nuclear Corporation
Melbourne, FL, USA) as compared to the same profile obtained from the treatment
planning system.
modulated radiotherapy (IMRT). We carried out the first investiga-
tion under an IMRT field, as described in Sec. II. We show results
in Figs. 5(a) and 5(b). Twelve irradiation segments are clearly visible
in the plots as separated current/charge signals, indicating that our
device can follow the fast and complex structure of this high confor-
mal radiotherapy technique. Dose profile relative to isocenter, mea-
sured with the perovskite-based dosimeter by moving it on a 10 cm
along a line (shown in Fig. 2) with a 5 mm pitch, is shown in Fig. 5(c).
It is compared to the same profile given by the treatment planning
system and by a commercial dosimetric system made of a flat silicon
diode bidimensional array (MAPCHECKTM by Sun Nuclear Corpo-
ration Melbourne, FL, USA).6 Our data are in very good agreement,
within 5% error, with the profile required by the TPS software and
measured the reference dosimetric system. This experimental test is
a valid proof that a perovskite-based device is indeed able to follow
the complex radiation delivering used in an IMRT technique and
opens the way to the application of inorganic perovskite dosimeters
for modern radiotherapy in conformal modality.
IV. CONCLUSIONS
A set of inorganic CsPbBr3 perovskite microcrystalline films
have been deposited on custom printed circuit boards (PCBs) and
tested as dosimeters with therapeutic X-ray beams. Current/charge
signals are linear with dose/dose rates under 6 MV/25 MV X-ray
uniform irradiation fields from linac, within dose and dose rate
ranges 0.1–5 Gy, 0.1–4 Gy/min of interest for clinical applications.
The sensitivity per unit volume found in our samples is about
70 nC/Gy mm3; the lowest measurable dose is about 6 mGy, far
below the machine lower delivering limit (1 cGy). The sensitivity per
unit volume calculated by our devices is smaller than the theoretical
value estimated for CsPbBr3. This is probably due to recombination
at defects. Acting as a sink of electrons and holes, they reduce the
charge collected at electrodes. As a result, the effective distance each
electron-hole pair travel apart before being recombined (so-called
effective charge collection length) is lower than the total thickness.
The effective active volume of the device is thus reduced to a frac-
tion of the entire volume of the sample. A recent study carried
out by some of the authors on similar samples pointed out that in
such a microcrystalline material, a non-negligible concentration of
defects, probably located at grain boundaries of the microcrystals
involved in the photoconductivity response of the devices at room
temperature.20 We note that this effect is also found in polycrys-
talline diamond dosimeters, e.g., in Ref. 21, where a device with an
active area 1.8 × 18 mm2 and a thickness of 300 µm, biased with
5 V, showed under a 6 MV X-ray beam of 38 nC/Gy sensitivity, indi-
cating a charge collection length of about 55 µm, significantly lower
than the total thickness of the sample. In silicon dosimeters, instead,
problems are related to the formation of radiation-induced defects,
which degrades the diffusion length and causes changes in the sen-
sitivity with the accumulated dose. To overcome this problem, the
thickness of the active volume, in most commercial devices, is tai-
lored opportunely to values around 20–50 µm.9 Hence, even if the
sensitivity per unit volume of silicon is quite higher, the actual sen-
sitivity of the device has a similar constraint found for diamond and
perovskite samples.
A first study in high conformal irradiation modality has also
been performed using an intensity modulated radiotherapy (IMRT)
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beam. A conformal dose distribution planned for prostate can-
cer treatment has been verified by measuring the current signal of
the perovskite device at several points within the irradiation field
map, along with a 10 cm-long profile passing through the isocenter,
with a 0.5 mm pitch. Our data showed a good agreement with the
dose distribution required by the treatment planning system, with
errors within 5%, indicating that our CsPbBr3 perovskite dosime-
ters can actually meet the stringent requirements of modern clinical
radiotherapy techniques.
In forthcoming studies, we plan to study the dosimetric per-
formance of single crystal inorganic perovskite samples, in view to
increase the sensitivity of our devices toward the theoretical limit.
In addition, we wish to investigate the effect of radiation-induced
defects on sensitivity, both for polycrystalline and single crystal
CsPbBr3, to finally assess the possible application of these materials
in radiotherapy.
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